What is the immunological response to BNT162b2 mRNA vaccine in immunocompromised patients?
Nicola Silvestris
Affiliations
Nicola Silvestris
Medical Oncology Unit, IRCCS Istituto Tumori ''Giovanni Paolo II'' of Bari, 70124 Bari, Italy; Department of Biomedical Sciences and Human Oncology, University of Bari ''Aldo Moro'', 70124 Bari, Italy; Correspondence author.
